DK389682A - Produkter, som udviser hepatitis b virus e antigener samt fremgangsmaade til fremstilling af saadanne antigener - Google Patents

Produkter, som udviser hepatitis b virus e antigener samt fremgangsmaade til fremstilling af saadanne antigener Download PDF

Info

Publication number
DK389682A
DK389682A DK389682A DK389682A DK389682A DK 389682 A DK389682 A DK 389682A DK 389682 A DK389682 A DK 389682A DK 389682 A DK389682 A DK 389682A DK 389682 A DK389682 A DK 389682A
Authority
DK
Denmark
Prior art keywords
antigenes
hepatitis
expect
virus
procedures
Prior art date
Application number
DK389682A
Other languages
English (en)
Inventor
Kenneth Murray
Patricia Mackay
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of DK389682A publication Critical patent/DK389682A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761Hepatitis B
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/826Viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/22Viral peptide or viral protein
    • Y10S930/223Hepatitis related
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/31Linker sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK389682A 1981-09-02 1982-08-31 Produkter, som udviser hepatitis b virus e antigener samt fremgangsmaade til fremstilling af saadanne antigener DK389682A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8126583 1981-09-02

Publications (1)

Publication Number Publication Date
DK389682A true DK389682A (da) 1983-03-03

Family

ID=10524270

Family Applications (1)

Application Number Title Priority Date Filing Date
DK389682A DK389682A (da) 1981-09-02 1982-08-31 Produkter, som udviser hepatitis b virus e antigener samt fremgangsmaade til fremstilling af saadanne antigener

Country Status (9)

Country Link
US (2) US4563423A (da)
EP (1) EP0075395A3 (da)
JP (3) JPS5852228A (da)
AU (1) AU8746582A (da)
CA (1) CA1209502A (da)
DK (1) DK389682A (da)
ES (1) ES515418A0 (da)
FI (1) FI823021L (da)
ZA (1) ZA826310B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
US4722891A (en) * 1984-06-20 1988-02-02 Board Of Regents, The University Of Texas System Methods and compositions for detection of Legionnaires' disease
JPS6137738A (ja) * 1984-07-31 1986-02-22 Tetsuo Nakamura B型肝炎ワクチン
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The HBsAgの精製方法
JPS61233700A (ja) * 1984-12-24 1986-10-17 ジエネンテク,インコ−ポレイテツド 分子クロ−ンされたエイズ関連ポリペプチド
US5853978A (en) * 1985-12-04 1998-12-29 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
US6534285B1 (en) 1984-12-24 2003-03-18 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
WO1987001128A1 (en) * 1985-08-15 1987-02-26 Amgen Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells
JPH084507B2 (ja) * 1985-10-03 1996-01-24 武田薬品工業株式会社 新規dnaおよびポリペプチド
EP0272483A1 (en) * 1986-12-19 1988-06-29 Abbott Laboratories Methods and materials for HBeAg production
ES2167304T3 (es) * 1987-06-22 2002-05-16 Medeva Holdings Bv Peptido que contiene el antigeno de superficie de la hepatitis b.
EP0311228A3 (en) * 1987-10-09 1990-05-02 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
ES2059601T3 (es) * 1988-05-11 1994-11-16 Abbott Lab Un inmunoensayo para la deteccion de anti-hbc en una muestra biologica.
US5122449A (en) * 1988-10-07 1992-06-16 Eastman Kodak Company Use of a protease in the extraction of chlamydial, gonococcal and herpes antigens
WO1990008960A1 (en) * 1989-02-06 1990-08-09 Imclone Systems, Inc. Stabilized hepatitis e antigen suitable for immunoassays
US5501948A (en) * 1989-02-06 1996-03-26 Imclone Systems Incorporated Stabilized hepatitis B e antigen suitable for immunoassays
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
DE4107612A1 (de) 1991-03-09 1992-09-10 Behringwerke Ag Rekombinante proteine mit der immunreaktivitaet des hepatitis b virus e antigens (hbeag), verfahren zu ihrer herstellung und ihre verwendung in immunoassays und impfstoffen
JP3225468B2 (ja) * 1992-08-28 2001-11-05 ダイナボット株式会社 抗体測定用試薬
AU2028297A (en) * 1996-03-19 1997-10-10 Akzo Nobel N.V. Method for predicting the outcome of hepatitis b infection
US6887464B1 (en) 1999-02-02 2005-05-03 Biocache Pharmaceuticals, Inc. Advanced antigen presentation platform
JP3847257B2 (ja) * 2000-08-11 2006-11-22 株式会社先端生命科学研究所 Hbvの検出又は測定方法
CA2419295A1 (en) * 2000-08-21 2002-02-28 Queen's University At Kingston Methods and kits for separation and detection of proteins in biological samples

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
BE796781A (nl) * 1973-03-15 1973-09-17 Den Bosch Maurits R M J Van Verbeterde armband of dergelijke
JPS50312A (da) * 1973-05-09 1975-01-06
US4164565A (en) * 1975-03-14 1979-08-14 New York Blood Center, Inc. Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
FR2303562A1 (fr) * 1975-03-14 1976-10-08 Community Blood Council Greate Nouvelle preparation d'antigene utilisable comme vaccin
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
US4021540A (en) * 1975-07-28 1977-05-03 Ortho Diagnostics Inc. Preparation of a hepatitis B immune globulin and use thereof as a prophylactic material
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
FR2398504A1 (fr) * 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a
US4197361A (en) * 1977-08-23 1980-04-08 Warner-Lambert Fluorescent immunoassay sandwich technique for HBs Ag
US4234564A (en) * 1977-12-19 1980-11-18 Merck & Co., Inc. Hepatitis B core antigen composition
FR2422685A1 (fr) * 1978-04-14 1979-11-09 Pasteur Institut Vecteurs, derives du bacteriophage lambda, permettant l'insertion et l'expression d'un gene, procaryote ou eucaryote, sous le controle du promoteur et de l'operateur de l'operon lactose de la bacterie escherichia coli
ZA792485B (en) * 1978-06-07 1980-06-25 New York Blood Center Inc Vaccine for active immunization containing hepatitis b surface and/or e-antigens
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen
FR2444713A1 (fr) * 1978-12-18 1980-07-18 Pasteur Institut Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
ES487106A0 (es) * 1978-12-22 1981-05-16 Biogen Nv Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen
US4617260A (en) * 1981-02-27 1986-10-14 Merck & Co., Inc. RIA assay for HBcAg

Also Published As

Publication number Publication date
EP0075395A2 (en) 1983-03-30
FI823021L (fi) 1983-03-03
US4563423A (en) 1986-01-07
US4758507A (en) 1988-07-19
FI823021A0 (fi) 1982-09-01
JPH06194368A (ja) 1994-07-15
AU8746582A (en) 1983-03-10
JPS5852228A (ja) 1983-03-28
ES8404186A1 (es) 1984-04-16
JPH06194369A (ja) 1994-07-15
ES515418A0 (es) 1984-04-16
EP0075395A3 (en) 1984-03-07
ZA826310B (en) 1983-07-27
CA1209502A (en) 1986-08-12

Similar Documents

Publication Publication Date Title
DK389682A (da) Produkter, som udviser hepatitis b virus e antigener samt fremgangsmaade til fremstilling af saadanne antigener
DK167482A (da) Fremgangsmaade til fremstilling af produkter,der er anvendelige til behandling af melanomer
DK457481A (da) Fremgangsmaade til formgivning af levneds eller nydelsesmidler
IT1154270B (it) Procedimento per la produzione di virus vaccini
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
DK267082A (da) Fremgangsmaade til fremstilling af et agglomereret, pulverformet maelkeprodukt
DE3688316T2 (de) Sicherheitssystem zur Gültigkeitsprüfung von Bauteilen.
NO165911C (no) Fremgangsmaate for fremstilling av syntesegass.
DK476682A (da) Peptidforbindelser samt fremgangsmaade til fremstilling af samme
NO159274C (no) Analogifremgangsmaate for fremstilling av fenyl-alifatisk-isoksazoler for bekjempelse av virus.
DK153388C (da) Fremgangsmaade til fremstilling af spraengstof, saadant til plast bundet spraengstof samt fremgangsmaade til fremstilling af formlegemer af naevnte spraengstof
DK65191A (da) Mellemprodukt til fremstilling af vitamin a eller estere deraf samt fremgangsmaade til dets fremstilling
DK10181A (da) Fremgangsmaade til fremstilling af azolylvinylketoner samt vedfremgangsmaaden anvendelige udgangsmaterialer
DK155781C (da) Fremgangsmaade til fremstilling af sintrede smaakugler af bauxit eller bauxitholdig bjergart, samt middel til udoevelse af fremgangsmaaden
NO157723C (no) Filterelement eller filter.
NO158136C (no) Fremgangsmaate til fremstilling av tiadiazolderivater.
DK149482A (da) Plastificeret evoh, fremgangsmaade til fremstilling af samme samt produkter omfattende samme
NO157704C (no) Oksalkylerte polyamidoaminer, fremgangsmaate for fremstilling av slike, samt anvendelse av dem.
NO832450L (no) Fremgangsmaate for innbyrdes sperring av to sammenskrudde elementer, samt elementer for gjennomfoering av fremgangsmaaten
NO845071L (no) Fremgangsmaate til fremstilling av ferromangan.
DK127782A (da) Fremgangsmaade til udvinding af produkter produceret af vaertsorganismer
DK423284D0 (da) Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser
FI822346A0 (fi) Foerfarande foer framstaellning av granuler innehaollande karbamid som huvudkomponent
DK570082A (da) 4-cyan-2-azetidinoner samt fremgangsmaade til fremstilling af saadanne
NO157422C (no) Fremgangsmaate til fremstilling av anti-t-lymfocytt-globulin.